EUVIMEDEUVIMED entdecken
Crossref

Comparison of interleukin-6 receptor antagonist and pulse steroid therapy in critically ill patients with COVID-19: retrospective analysis

Filiz Koç, Münire Babayiğit, Mustafa Alparslan Babayiğit, Oral Menteş, Emine Fırat Göktaş, Necla Dereli

Eurasian Journal of Anesthesiology and Intensive Care · 2025

DOI: 10.51271/eajaic-0022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Anesthesiology and Intensive Care, 2025. Verfasst von Filiz Koç und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Severe COVID-19 is characterized by acute respiratory distress syndrome accompanied by hypercytokinemia. In our study, we aimed to demonstrate the efficacy of the treatments such as interleukin-6 receptor antagonists and corticosteroids used in critically ill patients with COVID-19.

Methods

COVID-patients with cytokine storm treated in the intensive care unit between March 2020 and July 2021 were included in the study. Patients with increased neutrophil/lymphocyte ratio, lactate dehydrogenase, C-reactive protein, and ferritin and patients with oxygen saturations of 90% or lower, lymphopenia and fever were also considered to be in cytokine storm. Patients were divided into three groups: Tocilizumab Group, Steroid Group, Standard treatment Group.

Results

There was no statistically significant difference between the groups in terms of age and body mass index averages, gender ratios and concomitant diseases. The duration of stay in the intensive care unit and time on mechanical ventilation were found to be longer in the toculizimab group. There was no difference in mortality and the need for mechanical ventilation between the groups. On the other hand, ventilator-associated pneumonias were found to be higher in the pulse steroid group.

Conclusion

The close follow-up of the patients and early diagnosis of hypercytokinemia increase the success of the treatment, and accelerate to discharge from intensive care units. We think that it is important to select appropriate patients and pulse steroid is more suitable for use in cytokine storm because it is cheaper and more accessible.

Zitieren

APA

Koç, F., Babayiğit, M., Babayiğit, M. A., Menteş, O., Göktaş, E. F., & Dereli, N. (2025). Comparison of interleukin-6 receptor antagonist and pulse steroid therapy in critically ill patients with COVID-19: retrospective analysis. Eurasian Journal of Anesthesiology and Intensive Care. https://doi.org/10.51271/eajaic-0022

Vancouver

Koç F, Babayiğit M, Babayiğit MA, Menteş O, Göktaş EF, Dereli N. Comparison of interleukin-6 receptor antagonist and pulse steroid therapy in critically ill patients with COVID-19: retrospective analysis. Eurasian Journal of Anesthesiology and Intensive Care. 2025. doi:10.51271/eajaic-0022

BibTeX
@article{Ko2025,
  author = {Koç, Filiz and Babayiğit, Münire and Babayiğit, Mustafa Alparslan and Menteş, Oral and Göktaş, Emine Fırat and Dereli, Necla},
  title = {Comparison of interleukin-6 receptor antagonist and pulse steroid therapy in critically ill patients with COVID-19: retrospective analysis},
  journal = {Eurasian Journal of Anesthesiology and Intensive Care},
  year = {2025},
  doi = {10.51271/eajaic-0022}
}
Kostenlos starten →